Ignite Creation Date:
2025-12-24 @ 10:49 PM
Ignite Modification Date:
2025-12-25 @ 8:19 PM
Study NCT ID:
NCT02385669
Status:
TERMINATED
Last Update Posted:
2020-05-05
First Post:
2015-03-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma
Sponsor:
Craig L Slingluff, Jr
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-18
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-05
First Submit QC Date:
None
Study First Post Date:
2015-03-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-07
Results First Submit QC Date:
None
Results First Post Date:
2019-06-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-21
Last Update Post Date:
2020-05-05
Last Update Post Date Type:
ACTUAL